The benefits of self-monitoring for the NHS

Several studies5 have shown that patient self-monitoring improves the quality of oral anticoagulant therapy. Those who self manage have fewer thromboembolic events and lower mortality rates.

NICE estimate that 46% of patients who are indicated for warfarin or NOAC not presently anticoagulated. The reasons are multiple; variations in the quality of primary care, reluctance by GPs to recommend warfarin, capacity issues within anticoagulation clinics and the reluctance of patients to take warfarin due to concerns with the drug and the inconvenience it can bring6.

Now more than ever we people need to be offered greater choice and control over their care whilst PCTs/CCGs need also identify cost savings and productivity opportunities wherever possible.

Self-care, which includes self-monitoring, is a key NHS initiative. It has been identified that there is sub-optimal support for self-care which if addressed may add value improvements.7 For example, self-monitoring could help improve the current under emphasis of a person’s role in managing their illness.

Currently, anticoagulation clinics in NHS hospitals are struggling to cope with the volume of people that attend and they employ staff to take blood samples which are sent off to a laboratory to be tested. Results can take up to four hours to be processed which results in long delays for those attending. Some hospitals have started using portable testing devices to speed up this process to good effect. Nevertheless, self-monitoring is convenient for people and may reduce clinic attendance.

There is also a financial burden placed on the NHS in terms of managing people who are stable on oral anticoagulation therapy. Studies show8 if people were offered a portable INR tester to self-manage, about 25 percent of those stable would readily take up the self-management approach. This could have significant financial benefit even when taking in to account all primary care costs and funding on the prescription of the portable INR tester and test strips.

Read more about the importance of self-monitoring, inspirational stories and the benefits of self-monitoring for patients

5 Self-monitoring and self-management of oral anticoagulation (Review) – The Cochrane Collaboration
6 Management of patients with atrial fibrillation with new oral anticoagulants, Nicola Harrison-Tiffin, Programme Manager Public Health, NHS Bury
7 Do changes to patient-provider relationships improve quality and save money? – Health Foundation 2012
8 Data on file Atrial Fibrilation Association , AntiCoagulation Europe 2011

Comments are closed.

Sign the pledge to support our campaign. Improve the lives of thousands of patients

Click here and give us your support to help us make the case for change. Together, we will make this happen.


Download the latest newsletter

Click here to view all ACSMA newsletters and download your selected edition(s).


Latest News

December 2016: ACSMA Campaign Update

read more

NICE Quality Standard recommend.......

read more


Twitter

https://t.co/9IT8OikMu3
reply | retweet | favourite | 09:43 pm Feb 10

We have new case studies on the @ACSMA_UK website showcasing NHS self-monitoring excellence. https://t.co/koYY6Q1IPU #warfarin
reply | retweet | favourite | 06:01 pm Jan 12

Anticoagulation Therapy Services National Summit, 28 April 2017, London. See here for more info: https://t.co/TKIdp9wkLK
reply | retweet | favourite | 05:27 pm Jan 12

follow us on Twitter